XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants
Immunology
[키워드] ACE-2
acute respiratory syndrome
addition
African
Against
Angiotensin converting enzyme-2
assays
Brazil
conducted
Contact
coronavirus
coronavirus disease
COVID-19
Deletion
demonstrated
dose
effective
Effectiveness
Efficacy and safety
epitope
Epitopes
evaluate
evaluated
Heterologous
Interaction
Live virus
lung
mAbs
maintain
mitigate
moderate
moderate-to-severe COVID-19
monoclonal antibody
Multiple
Mutation
neutralization
neutralization capacity
neutralizing antibody
Patient
patients hospitalized
Pneumonia
polyclonal
polyclonal antibody
polyclonal antibody (PAb)
Protein
raised
RBD
Receptor binding
Receptor binding domain
reduce
S protein
Safe
SARS-CoV-2
selective
severity
South
spike
Substitution
target
the RBD
the Spike
therapeutic
transduced
Trial
United Kingdom
variant
variants
variants of concern
Vero E6
Vero E6 cell
Viral load
Wuhan
Wuhan-Hu-1
[DOI] 10.3389/fimmu.2021.761250 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.761250 PMC 바로가기 [Article Type] Immunology